HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

torcetrapib

inhibits cholesteryl ester transfer protein; modest increase in blood pressure led to reevaluation
Also Known As:
CP 529,414; CP 529414; CP-529,414; CP-529414; CP529,414; CP529414
Networked: 76 relevant articles (4 outcomes, 32 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kastelein, John J P: 6 articles (11/2012 - 04/2007)
2. Shear, Charles L: 6 articles (11/2012 - 03/2007)
3. Schaefer, Ernst J: 4 articles (06/2013 - 05/2005)
4. Duggan, William T: 4 articles (11/2012 - 03/2007)
5. Barter, Philip J: 4 articles (11/2012 - 04/2007)
6. Revkin, James H: 4 articles (07/2007 - 03/2007)
7. Rye, Kerry-Anne: 3 articles (11/2012 - 08/2011)
8. Hermann, Matthias: 3 articles (07/2012 - 01/2009)
9. Tardif, Jean-Claude: 3 articles (08/2011 - 03/2007)
10. Asztalos, Bela F: 3 articles (12/2007 - 05/2005)

Related Diseases

1. Coronary Disease (Coronary Heart Disease)
2. Atherosclerosis
3. Coronary Artery Disease (Coronary Atherosclerosis)
4. Cardiovascular Diseases (Cardiovascular Disease)
5. Atherosclerotic Plaque (Atheroma)

Related Drugs and Biologics

1. HDL Cholesterol
2. dalcetrapib
3. atorvastatin (Lipitor)
4. Lipoproteins (Lipoprotein)
5. Niacin (Nicotinic Acid)
6. Cholesterol
7. LDL Cholesterol
8. anacetrapib
9. Cholesterol Ester Transfer Proteins
10. Lipids